Align Serine hydroxymethyltransferase; SHMT; Serine methylase; L-threonine/L-allo-threonine aldolase; EC 2.1.2.1; EC 4.1.2.48 (characterized)
to candidate WP_068111138.1 I601_RS14510 glycine hydroxymethyltransferase
Query= SwissProt::D3DKC4 (427 letters) >NCBI__GCF_001653335.1:WP_068111138.1 Length = 481 Score = 372 bits (955), Expect = e-107 Identities = 209/459 (45%), Positives = 275/459 (59%), Gaps = 53/459 (11%) Query: 6 NTDAEIYEAIVKEYERQFYHLELIASENFTSLAVMEAQGSVMTNKYAEGLPHKRYYGGCE 65 + + I EA E Q L+LIASEN+ S AV+ G+ ++KYAEG R+Y GC+ Sbjct: 22 SVEPRIAEATRAELADQRASLKLIASENYASPAVLMTMGTWFSDKYAEGTVGHRFYAGCQ 81 Query: 66 FVDIAEDLAIERAKALFDAEHANVQPHSGTQANMAVYMAVLKP----------------- 108 VD E +A E A+ LF AE+A VQPHSG AN+ + ++L Sbjct: 82 NVDTVESIAAEHARELFGAEYAYVQPHSGIDANLVAFWSILAHRVEGPWLEKAQAKNVNE 141 Query: 109 --------------GDTIMGMDLSHGGHLTHGAKVNFSGKIYNAVYYGVHPETHLIDYDQ 154 ++GM L GGHLTHG + N SGK+++ YG P T L+DYD Sbjct: 142 LTDADWESLRKELGNQRLLGMSLDAGGHLTHGFRPNISGKMFHQQQYGTDPTTGLLDYDA 201 Query: 155 LYRLAKEHKPKLIVGGASAYPRVIDWAKLREIADSVGAYLMVDMAHYAGLIAGGVYP--- 211 + A+E KP ++V G SAYPR +D+AK+REIAD VGA LMVDMAH+AGL+AGGV+ Sbjct: 202 VAAKAREFKPLVLVAGYSAYPRRVDFAKMREIADEVGATLMVDMAHFAGLVAGGVFTGDE 261 Query: 212 NPVPYAHFVTSTTHKTLRGPRSGFILCKKEFAKDIDKSVFPGIQGGPLMHVIAAKAVAFK 271 NPVP+AH VT+TTHK+LRGPR G +L +E+A +D+ P + GGPL HV+AAKAVAF Sbjct: 262 NPVPHAHVVTTTTHKSLRGPRGGMVLATEEYAPSVDRGC-PMVLGGPLSHVMAAKAVAFA 320 Query: 272 EAMSQEFKEYARQVVANARVLAEEFIKEGFKVVSGGTDSHIVLLDLRDTGLTGREVEEAL 331 EA F+ YA+QV NA+ LAE F+ G +V+GGTD+H+VLLD+ GLTGR+ E AL Sbjct: 321 EARQDSFRTYAQQVADNAKSLAEGFLTRGADLVTGGTDNHLVLLDVSKYGLTGRQAETAL 380 Query: 332 GKANITVNKNAVPFDPLPPVKTSGIRLGTPAMTTRGMKEDQMRIIARLISKVIKN----- 386 A + N+N+VP DP TSGIRLGTPA+TTRG D+ +A LI V+ N Sbjct: 381 LDAGVVTNRNSVPADPNGAWYTSGIRLGTPALTTRGFGHDEFDTVADLIVDVLSNTQAGT 440 Query: 387 ------------IGDEKVIEYVRQEVIEMCEQFPLYPEL 413 +GD V + V+ EM ++ PLYP L Sbjct: 441 TKAGGPSKASYVLGD-GVADRVKAASAEMLDKHPLYPGL 478 Lambda K H 0.319 0.136 0.395 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 592 Number of extensions: 33 Number of successful extensions: 4 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 2 Number of HSP's successfully gapped: 2 Length of query: 427 Length of database: 481 Length adjustment: 33 Effective length of query: 394 Effective length of database: 448 Effective search space: 176512 Effective search space used: 176512 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 51 (24.3 bits)
This GapMind analysis is from Jul 25 2024. The underlying query database was built on Jul 25 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory